Amphotericin B Cholesteryl Sulfate Complex Injection
Last Updated: October 20, 2014
Products Affected - Description
Amphotec, lyophilized powder, Alkopharma
50 mg vial (NDC 66435-0301-51)
100 mg vial (NDC 66435-0302-01)
Reason for the Shortage
- Kadmon had acquired Three Rivers Pharmaceuticals in October 2010 and Amphotec was part of the product portfolio. Kadmon sold Amphotec to Alkopharma.
- Alkopharma was the sole supplier of amphotericin b cholesteryl sulfate lipid complex. The company’s phone is no longer in service. The contracted manufacturer of Amphotec was Ben Venue Laboratories.
- Ben Venue closed its plant in Bedford, Ohio in July 2014.
- The shortage of amphotericin b cholesteryl sulfate lipid complex is not affecting other amphotericin formulations.
No presentations are available.
Estimated Resupply Dates
Amphotec is not available.
October 20, 2014; July 14, 2014; March 24, 2014; January 2, 2014; October 9, 2013; July 11, 2013; April 12, 2013; February 13, 2013; September 10, 2012; July 6, 2012; February 15, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.